Concepedia

Yasuhiro Oki

YO

145

Publications

11.4K

Citations

52

H-Index

2000

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Seagen (United States)

Aichi Cancer Center

Washington University in St. Louis

Yasuhiro Oki is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2000–2024

145

Publications

145

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Joseph M. Connors, Wojciech Jurczak, David J. Straus et al. · New England Journal of Medicine · 2017 · 738 citations · Full text

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

Hagop M. Kantarjian, Yasuhiro Oki, Guillermo Garcia‐Manero et al. · Blood · 2006 · 687 citations · Full text

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Mark W. Clemens, L. Jeffrey Medeiros, Charles E. Butler et al. · Journal of Clinical Oncology · 2015 · 414 citations · Full text

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard et al. · The Lancet Oncology · 2016 · 375 citations · Full text

, , +7

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome–negative CML, and megakaryocytic leukemia

Jaroslav Jelı́nek, Yasuhiro Oki, Vazganush Gharibyan et al. · Blood · 2005 · 370 citations · Full text

Rows per page

1–5 of 145